Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06161701

Steroid Diabetes in Patients With Kidney Disease

A Study on the Influencing Factors of Glucocorticoid Induced Elevated Blood Glucose in Nephrotic Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Zhejiang Provincial People's Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.

Detailed description

1. Patients with nephrosis who had taken glucocorticoid for the first time were followed up, and those who had diabetes themselves were excluded. 2. Regularly follow up and record information on glucocorticoid medication, medications that have an impact on blood sugar, fasting blood sugar, 2-hour postprandial blood sugar, and glycated hemoglobin. 3. Notify relevant doctors of any cases of elevated blood sugar. 4. The total follow-up time is 1 year.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2024-01-10
Primary completion
2026-12-31
Completion
2027-02-28
First posted
2023-12-08
Last updated
2024-04-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06161701. Inclusion in this directory is not an endorsement.